1995 Fiscal Year Final Research Report Summary
Regulation of immunities induce by GVHD, HVGD with cytokine abnormalities
Project/Area Number |
06670499
|
Research Category |
Grant-in-Aid for General Scientific Research (C)
|
Allocation Type | Single-year Grants |
Research Field |
内科学一般
|
Research Institution | Juntendo University School of Medicine |
Principal Investigator |
HIRANO Takao Juntendo University School of Medicine, Intermedicine, Associate Prof., 医学部, 助教授 (10165186)
|
Co-Investigator(Kenkyū-buntansha) |
OKUMURA Ko Juntendo University School of Medicine, Immunology, Prof., 医学部, 教授 (50009700)
|
Project Period (FY) |
1994 – 1995
|
Keywords | GVHD / HVGD / IL-4 / IgE / IgE allotype |
Research Abstract |
It is well known that GVHD and HVGD are severe complications after transplantation tharapy for immunotherapies, we recently established a murine model of BMT-GVHD that was induced by the injection of parental bone marrow cells plus spleen cells as a source of T cells into irradiated F1 recipients. We found that increased serum IgE and IgG1 levels were correlated with BMT-GVHD such as liver disease and splenomegaly. The allotype of increased IgE levels in BMT-GVHD was IgE^a of donor origin, not IgE^b of host origin. We also found that in the thymus of murine BMT-GVHD, the CD4^+ CD8^+ double positive (DP) T cells were decreased, but the CD4^+ CD8^- or CD4^- CD8^+ single positive (SP) T cells were increased. When the recipients were treated with anti-IL-4 antibody (11B11), the increase of IgE and IgG1 was markedly reduced and liver disease and splenomegaly were also prevented. Moreover, abnormal T cell differentiation and maturation were suppressed. These observations suggest that IL-4 plays an important role in immunoregulation or pathogenesis of allogeneic effects and 11B11 prevents immunodysfunction including T cell differentiaiton in the thymus or the spleen and autoimmune symptoms in murine BMT-GVHD.
|
Research Products
(10 results)